Literature DB >> 2551865

Nonangiogenic and nonlymphomatous sarcomas of the canine spleen: 57 cases (1975-1987).

M J Weinstein1, J L Carpenter, C J Schunk.   

Abstract

The case records of and histopathologic findings in 57 dogs with nonangiogenic and nonlymphomatous splenic sarcomas were reviewed. Splenic neoplasms in these dogs included leiomyosarcoma, fibrosarcoma, undifferentiated sarcoma, liposarcoma, osteosarcoma, chondrosarcoma, myxosarcoma, rhabdomyosarcoma, and fibrous histiocytoma. The clinical signs associated with splenic sarcoma included anorexia or decreased appetite, abdominal distention, polydipsia, lethargy, vomiting, weight loss, and weakness. An abdominal mass was detected in 86% of the dogs by use of abdominal palpation (63%), and/or abdominal radiography (74%). The diagnosis was based on histopathologic findings in the spleen. Abdominal exploratory surgery was performed on 43 of the 57 dogs. Twenty-seven dogs were treated by splenectomy, and 16 were euthanatized at the time of surgery because of widespread metastatic lesions. Of the 14 dogs on which surgery was not performed, 11 were euthanatized on the basis of results of preoperative diagnostic tests, and the remaining 3 dogs had splenic neoplasms that were incidental findings at necropsy. Of the 27 surgically treated dogs, 5 died in the immediate postoperative period, 12 died or were euthanatized within 1 year after splenectomy, and only 5 dogs survived greater than or equal to 1 year. Three dogs were lost to follow-up evaluation, and 2 were still alive 6 and 7 months after surgery. The median survival time of the 22 dogs for which survival was known was 2.5 months. The median survival time for 11 dogs with no obvious metastasis at the time of splenectomy was 9 months.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2551865

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  6 in total

1.  Primary splenic mesenchymal chondrosarcoma in a dog.

Authors:  Jonathan M Miller; Richard Walshaw; Andrea C Bourque
Journal:  Can Vet J       Date:  2005-02       Impact factor: 1.008

2.  Retrospective immunohistochemical investigation of suspected non-visceral leiomyosarcoma in dogs.

Authors:  Rachel V Brady; Robert B Rebhun; Katherine A Skorupski; Jenna H Burton; Sami Al-Nadaf; Eunju Choi; Jennifer L Willcox
Journal:  J Vet Diagn Invest       Date:  2022-03-15       Impact factor: 1.569

3.  Canine Non-Angiogenic, Non-Myogenic Splenic Stromal Sarcoma: a Retrospective Clinicopathological Analysis and Investigation of Podoplanin as a Marker of Tumour Histogenesis.

Authors:  Brittany M Wittenberns; Douglas H Thamm; Eric P Palmer; Daniel P Regan
Journal:  J Comp Pathol       Date:  2021-08-27       Impact factor: 1.083

4.  Extraskeletal chondrosarcoma in the tongue of a dog: case report and retrospective analysis of 236 tongue masses (2011-2019).

Authors:  Michael C Rahe; Tracey Westegaard; Michael Yaeger
Journal:  J Vet Diagn Invest       Date:  2020-03-19       Impact factor: 1.279

5.  Development and validation of a multivariable model and online decision-support calculator to aid in preoperative discrimination of benign from malignant splenic masses in dogs.

Authors:  Kristine E Burgess; Lori Lyn Price; Ryan King; Manlik Kwong; Eliza Grant; Katherine A Olson; Jeremiah A Lyons; Nicholas A Robinson; Kristin M Wendelburg; John Berg
Journal:  J Am Vet Med Assoc       Date:  2021-06-15       Impact factor: 1.936

6.  Locally advanced leiomyosarcoma of the spleen. A case report and review of the literature.

Authors:  Paolo Piovanello; Vincenzo Viola; Giampaolo Costa; Massimiliano Carletti; Andrea Cecera; Fabrizio Turchetta; Roberto Iudicone; Giuseppe Catalano; Antonello Santucci; Franco Recchia; Loredana Fiorillo; Maria Antonella Menichella; Giovanni Baiano
Journal:  World J Surg Oncol       Date:  2007-11-28       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.